Form 4: Madrigal Pharmaceuticals General Counsel Sells Shares to Cover Tax Obligations

Madrigal Pharmaceuticals' General Counsel, Shannon T. Kelley, sold 277 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Shannon T. Kelley, General Counsel at Madrigal Pharmaceuticals, sold 277 shares of common stock on January 17, 2025.
• The sale was executed at a price of $273.41 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of restricted stock units.
• The sale was automatic and not at the discretion of the reporting person.

Sentiment

Score: 5

Explanation: This is a routine transaction related to tax obligations and does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• Many companies use restricted stock units as part of their compensation packages, which often trigger tax liabilities upon vesting.
• The sale of 277 shares is a relatively small transaction and is not unusual for a company of Madrigal's size.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is not expected to be significant.

Key Dates

Keywords

Madrigal Pharmaceuticals, MDGL, insider trading, stock sale, Form 4, restricted stock units, tax obligations, Shannon T. Kelley, General Counsel